Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction

Abstract. The aim of this study was to determine which brain structures show the greatest influence of partial volume effects (PVE) in single-photon emission tomography (SPET) studies on Alzheimer's disease (AD). Brain perfusion SPET was performed in 30 patients with probable AD and 62 age-matched healthy volunteers. SPET images were corrected for PVE using grey matter volume segmented from magnetic resonance images. The most prominent changes after PVE correction were observed in the medial temporal structures. The PVE correction revealed a selective decrease in regional cerebral blood flow (rCBF) in the parahippocampal gyrus of AD without rCBF decreases in the hippocampus, which had been observed before correction. This correction seems to be essential in order to achieve accurate measurements of rCBF in SPET, which has limited spatial resolution.

[1]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[2]  T. Uema,et al.  Abnormal regional cerebral blood flow in childhood autism. , 2000, Brain : a journal of neurology.

[3]  Karl J. Friston,et al.  Human Brain Function , 1997 .

[4]  G. Alexander,et al.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.

[5]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[6]  L. Pincherle,et al.  Principles and Methods of Band Theory , 1969 .

[7]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  K. Ishii,et al.  Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[10]  H. Hoshi,et al.  High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.